Register entry
- Registered sites
- 0
- Active NDC listings
- 38
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
3838 active NDC listings: 38 human prescription drug. By marketing category: ANDA 38.
| Dosage form | NDCs |
|---|---|
| capsule | 21 |
| tablet | 13 |
| capsule, extended release | 4 |
| Route | NDCs |
|---|---|
| oral | 38 |
| Labeller name on the listing | NDCs |
|---|---|
| creekwood pharmaceuticals llc | 38 |
Catalogue
Marketed products
38| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ATOMOXETINE | atomoxetine | capsule, oral | 82619-115ANDA |
| ATOMOXETINE | atomoxetine | capsule, oral | 82619-116ANDA |
| ATOMOXETINE | atomoxetine | capsule, oral | 82619-117ANDA |
| ATOMOXETINE | atomoxetine | capsule, oral | 82619-118ANDA |
| ATOMOXETINE | atomoxetine | capsule, oral | 82619-119ANDA |
| ATOMOXETINE | atomoxetine | capsule, oral | 82619-120ANDA |
| ATOMOXETINE | atomoxetine | capsule, oral | 82619-121ANDA |
| FENOFIBRATE | fenofibrate | tablet, oral | 82619-101ANDA |
| FENOFIBRATE | fenofibrate | tablet, oral | 82619-102ANDA |
| Gabapentin | Gabapentin | capsule, oral | 82619-142ANDA |
| Gabapentin | Gabapentin | capsule, oral | 82619-143ANDA |
| Gabapentin | Gabapentin | capsule, oral | 82619-144ANDA |
| Gabapentin | Gabapentin | tablet, oral | 82619-145ANDA |
| Gabapentin | Gabapentin | tablet, oral | 82619-146ANDA |
| HALOPERIDOL | haloperidol | tablet, oral | 82619-105ANDA |
| HALOPERIDOL | haloperidol | tablet, oral | 82619-106ANDA |
| HALOPERIDOL | haloperidol | tablet, oral | 82619-107ANDA |
| HALOPERIDOL | haloperidol | tablet, oral | 82619-108ANDA |
| HALOPERIDOL | haloperidol | tablet, oral | 82619-109ANDA |
| HALOPERIDOL | haloperidol | tablet, oral | 82619-110ANDA |
| HYDROXYCHLOROQUINE SULFATE | hydroxychloroquine sulfate | tablet, oral | 82619-131ANDA |
| NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | Nitrofurantoin (monohydrate/macrocrystals) | capsule, oral | 82619-147ANDA |
| PREGABALIN | Pregabalin | capsule, oral | 82619-122ANDA |
| PREGABALIN | Pregabalin | capsule, oral | 82619-123ANDA |
| PREGABALIN | Pregabalin | capsule, oral | 82619-124ANDA |
| PREGABALIN | Pregabalin | capsule, oral | 82619-125ANDA |
| PREGABALIN | Pregabalin | capsule, oral | 82619-126ANDA |
| PREGABALIN | Pregabalin | capsule, oral | 82619-127ANDA |
| PREGABALIN | Pregabalin | capsule, oral | 82619-128ANDA |
| PREGABALIN | Pregabalin | capsule, oral | 82619-129ANDA |
| Propranolol Hydrochloride | Propranolol Hydrochloride | capsule, extended release, oral | 82619-132ANDA |
| Propranolol Hydrochloride | Propranolol Hydrochloride | capsule, extended release, oral | 82619-133ANDA |
| Propranolol Hydrochloride | Propranolol Hydrochloride | capsule, extended release, oral | 82619-134ANDA |
| Propranolol Hydrochloride | Propranolol Hydrochloride | capsule, extended release, oral | 82619-135ANDA |
| RIZATRIPTAN BENZOATE | rizatriptan benzoate | tablet, oral | 82619-111ANDA |
| RIZATRIPTAN BENZOATE | rizatriptan benzoate | tablet, oral | 82619-112ANDA |
| SILODOSIN | silodosin | capsule, oral | 82619-113ANDA |
| SILODOSIN | silodosin | capsule, oral | 82619-114ANDA |
Compare
Other companies listing pregabalin
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Olon USA LLC11 sites · 185 NDC
- Hetero Labs Limited8 sites · 167 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- SOLARA ACTIVE PHARMA SCIENCES LIMITED6 sites · 40 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Unichem Laboratories Limited, India5 sites · 272 NDC
- Torrent Pharma, Inc.5 sites · 184 NDC
Enquiry
Common questions
- Is Creekwood Pharmaceuticals LLC FDA approved?
- Creekwood Pharmaceuticals LLC holds no registered establishment of its own; 38 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Creekwood Pharmaceuticals LLC make?
- 38 products are listed under Creekwood Pharmaceuticals LLC in the openFDA NDC Directory, most often as capsule; tablet; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.